ARTICLE SUMMARY:
Part 2 of our conversation with J&J's Paul Coplan on current and future medtech applications of real-world evidence; the UK MHRA's AI Airlock pilot, a regulatory sandbox for AI device developers to brainstorm solutions to oversight problems; Knobbe Martens on securing permanent injunctions to protect medtech IP; a new face at CDRH’s Office of Product Evaluation and Quality; highlights from a summer of policymaking; and a graphic look at CMS payment and coverage trends.
